Drugmakers in China Face U.S. Scrutiny

Drugmakers in China Face U.S. Scrutiny Play

Dec. 11 (Bloomberg) –- Bloomberg’s Mia Saini reports on the U.S. supervising more closely the active ingredients in drugs that China supplies, with the FDA tripling the number of regulators in the country. She speaks to Angie Lau on Bloomberg Television’s “First Up.” (Source: Bloomberg)

  • On Air Now

    PAID PROGRAMMING Watch Now

  • Next

    PAID PROGRAMMING

blog comments powered by Disqus